Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients (Pages: 148-150)

Najmeh Salehi , Amir Amiri-Yekta , Mehdi Totonchi *,


The etiologic agent SARS-CoV-2 has caused the outbreak of COVID-19 which is spread widely around the world. It is vital to uncover and investigate the full genome sequence of SARS-CoV-2 throughout the world to track changes in SARS-CoV-2. To this purpose, SARS-Cov-2 full genome sequence profiling of 20 patients in Iran and different countries that already had a travel history to Iran or contacts with Iranian cases were provided from the GISAID database. The bioinformatics analysis showed 44 different nucleotide mutations that caused 28 nonsynonymous mutations in protein sequences in Iranian data. R207C, V378I, M2796I, L3606F, and A6407V in ORF1ab were common mutations in these sequences in comparison with the full genome of the SARS-CoV-2 sequence (NC_045512.2). Also, some of the detected mutations only were found in Iranian data in comparison with all the available sequences of SARS-CoV-2. The position of S protein mutation showed they were far from the binding site of this protein with angiotensin-converting enzyme-2 (ACE2) as the host cell receptor. These results can be helpful to design specific diagnostic tests, trace the SARS-CoV-2 sequence changes in Iran, and explore therapeutic drugs and vaccines.